Revista Española de Salud Pública
versión impresa ISSN 1135-5727
CRUZ ROJO, Concepción; GARCIA GIL, Carmen; NIETO VERA, Juan y MONROY MORCILLO, Ana. Impact of Systematic Vaccination with the Antimeningococcal C Conjugated Vaccine in a Health Area in Andalusia. Rev. Esp. Salud Publica [online]. 2005, vol.79, n.6, pp.655-663. ISSN 1135-5727.
Background: A retrospective longitudinal study of population incidence was made to assess the effectiveness of meningococcal serogroup C conjugate vaccine, after its mass introduction in children in the geographic area of a health district, measuring its population impact, and we have studied the state of the meningococcal disease. Methods: Vaccine coverage in children born between 1991 and 2001, and rates of incidence in declared cases of meningococcal disease in seven epidemiological seasons (1997/98 to 2003/04) were calculated. The impact of vaccination against serogroup C meningitis was assessed comparing the average annual rates of previous and later seasons to the vaccination campaigns in population younger and older than 10, using the Fisher exact test. Results: In all the study period, 109 cases of meningococcal disease were declared, of which 50 were of serogroup C meningococcal disease. Starting from 2000/2001 season the incidence of serogroup C disease decreased in the population below 10. In this age group, the annual average rate of post-vaccine seasons decreases in respect to pre-vaccine (from 8.2 to 2.0 per 100,000 inhabitants) showing a statistically significant difference. In the population above 10 years, this incidence reduction was not observed. In the study period, no case of vaccine failure was declared. Conclusions: The absence of vaccine failure and the impact observed on the incidence of serogroup C meningococcal disease in children under 10 suggests the effectiveness of this new conjugate vaccine, together with suitable vaccination conditions (vaccination schedule, high catch-up, etc.) which are developing in our health district.
Palabras clave : Meningococcal disease; Conjugated vaccine; Effectiveness; Vaccine.